Travere Therapeutics Inc. (TVTX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 866 |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q2 2026 | |||||
| ≡ | Polen Capital Management | Buy | 34,315 | 0.02 | |
| Q2 2025 | |||||
| ≡ | Viking Global Investors | Sell 100.00% | 2,601,922 | 0.15 | |
| Q1 2025 | |||||
| ≡ | Viking Global Investors | Reduce 10.34% | 300,003 | 0.02 | |
| Q4 2024 | |||||
| ≡ | Viking Global Investors | Buy | 2,901,925 | 0.16 | |
| Q4 2016 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 148,661 | 0.04 | |
| Q3 2016 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 148,661 | 0.04 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.